<?xml version="1.0" encoding="UTF-8"?>
<p>Consecutive HIV-infected adults initiating ART in 2 urban clinics in Lusaka, Zambia, and 4 rural clinics in Ancuabe, Mozambique, were enrolled between May 2013 and November 2014. Alongside HCV-related testing, patients received a clinical examination and laboratory screening including a full blood count, transaminases, serum creatinine, and a CD4 cell count. In addition, a detailed questionnaire on risk factors for liver disease was administered in face-to-face interviews with all patients in Zambia and a subsample of the cohort in Mozambique. This survey included questions on alcohol and drug consumption, risk factors for blood-borne infections, and past history of sexually transmitted infections. All data were entered into an electronic database for clinical care, monitoring, evaluation, and reporting purposes. All patients provided written informed consent to participate in a prospective substudy within the framework of the International epidemiological Databases to Evaluate AIDS in Southern Africa (IeDEA-SA) [
 <xref rid="OFW049C7" ref-type="bibr">7</xref>]. The Biomedical Research Ethics Committee of University of Zambia School of Medicine, the Institutional Review Board of University of North Carolina at Chapel Hill, and the Comité Nacional de Bioética para a Saúde, República de Moçambique, approved the study.
</p>
